Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

New study explores the association between epilepsy drug levetiracetam and Alzheimer’s

Staff Writer
Staff Writer 2 months ago
Updated 2022/12/01 at 8:57 AM
Share
SHARE

Researchers at Indiana University recently published their findings in Alzheimer’s & Dementia: Translational Research & Clinical Interventions about the relationship between epilepsy drug levetiracetam and Alzheimer’s disease.

The study focused on how the epilepsy drug may be used as a possible therapeutic intervention for Alzheimer’s among children and adults.

The epilepsy drug levetiracetam works by binding to a specific receptor in the brain known as SV2A.

“We’re trying to do research not only to advance our basic understanding of how disease progresses in Alzheimer’s disease, but how can you possibly apply new therapeutic approaches that are not specifically targeting amyloid and tau,” a news release reads.


“The purpose of our studies was to establish a pharmacokinetic/pharmacodynamic (PK/PD) relationship with LEV in an amyloidogenic mouse model of AD to enable predictive preclinical to clinical translation, using the rigorous preclinical testing pipeline of the Model Organism Development and Evaluation for Late-Onset Alzheimer’s Disease Preclinical Testing Core.”

“This study represents the first report of PK/PD assessment of LEV in 5XFAD mice. Overall, these results highlighted non-linear kinetics based on dose and sex,” according to the study’s authors.

You Might Also Like

New study explores test that can detect Alzheimer’s years before diagnosis

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

New research finds Alzheimer’s risk factors affect males and females very differently

Study establishes critical role in regulating excessive folding of gyri in brain

TAGGED: levetiracetam, alzheimers, epilepsy
Staff Writer November 30, 2022
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Study finds cannabidiol oil induces no therapeutic effects for cancer patients
Next Article Study finds pandemic stress physically aged the brains of teens

Recommended

Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
Clinical

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

1 Min Read
Clinical

New research finds Alzheimer’s risk factors affect males and females very differently

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?